Clinical Trial Update: An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase exploratory study assessing the safety and imaging feasibility of an 18F-labeled hydroxyphenethylguanidine PET tracer in patients with cardiomyop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• 18F-labeled hydroxyphenethylguanidine (hydroxyphenethylguanidine)

Snippet

Sponsor: University of Michigan | Conditions: Cardiomyopathy | EARLY_Phase 1 | Status: COMPLETED